Stay updated on INCAGN01876 Combo Immune Therapies Clinical Trial
Sign up to get notified when there's something new on the INCAGN01876 Combo Immune Therapies Clinical Trial page.

Latest updates to the INCAGN01876 Combo Immune Therapies Clinical Trial page
- Check7 days agoChange DetectedAdded 'Gastric cancer' as a keyword/MeSH term to the study page to improve indexing and searchability. No changes to the study design, eligibility criteria, or outcomes.SummaryDifference0.0%

- Check14 days agoChange DetectedRevision: v3.4.2 was added and the government-funding operating-status notice was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check21 days agoChange DetectedA new site-wide notice regarding potential delays due to government funding was added. The page revision was updated to v3.4.1 and the previous v3.4.0 revision was removed.SummaryDifference0.2%

- Check28 days agoChange DetectedShow glossary feature added; 'Last Update Submitted that Met QC Criteria' field added; No FEAR Act Data added; site revision updated to v3.4.0. Removed the previous lowercase labels for QC criteria and No FEAR Act data, and the old revision v3.3.4.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision: v3.3.4 now appears on the page in place of Revision: v3.3.3. This is a minor administrative update with no impact on study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check64 days agoChange DetectedLocations section updated to expand participating sites across the US and Australia, including Chevigny and multiple state/territory entries. The update is labeled as Revision: v3.3.3.SummaryDifference1%

Stay in the know with updates to INCAGN01876 Combo Immune Therapies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INCAGN01876 Combo Immune Therapies Clinical Trial page.